Published in Blood on August 15, 1994
Inducible apoptosis as a safety switch for adoptive cell therapy. N Engl J Med (2011) 6.14
Inducible caspase 9 suicide gene to improve the safety of allodepleted T cells after haploidentical stem cell transplantation. Biol Blood Marrow Transplant (2007) 2.33
Mesenchymal stem cells prevent hypertrophic scar formation via inflammatory regulation when undergoing apoptosis. J Invest Dermatol (2014) 1.90
Long-term in vivo monitoring of mouse and human hematopoietic stem cell engraftment with a human positron emission tomography reporter gene. Proc Natl Acad Sci U S A (2013) 0.96
Adoptive T-cell therapy: adverse events and safety switches. Clin Transl Immunology (2014) 0.91
Redirected infection of directly biotinylated recombinant adenovirus vectors through cell surface receptors and antigens. Proc Natl Acad Sci U S A (1999) 0.91
Acute graft versus host disease due to T lymphocytes recognizing a single HLA-DPB1*0501 mismatch. J Clin Invest (1996) 0.89
Adoptive T-cell therapy for B-cell malignancies. Expert Rev Hematol (2009) 0.88
Control of graft-versus-host disease with maintenance of the graft-versus-leukemia effect in a murine allogeneic transplant model using retrovirally transduced murine suicidal lymphocytes. Exp Hematol (2007) 0.82
A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy. J Hematol Oncol (2017) 0.77
Antibody gene transfer with adeno-associated viral vectors as a method for HIV prevention. Immunol Rev (2017) 0.77
Editorial: Improving the safety of cell therapy products by suicide gene transfer. Front Pharmacol (2015) 0.75
Bacterial community structures of phosphate-removing and non-phosphate-removing activated sludges from sequencing batch reactors. Appl Environ Microbiol (1995) 11.83
Structure of the 5' ends of immunoglobulin genes: a novel conserved sequence. Proc Natl Acad Sci U S A (1984) 7.74
Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell (1992) 5.87
Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proc Natl Acad Sci U S A (1993) 4.73
Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood (2000) 4.34
Identification of a novel Y branch structure as an intermediate in trypanosome mRNA processing: evidence for trans splicing. Cell (1986) 4.31
Directed tagging of the Arabidopsis FATTY ACID ELONGATION1 (FAE1) gene with the maize transposon activator. Plant Cell (1995) 4.15
Procedures for the purification of interleukin 3 to homogeneity. J Immunol (1982) 3.96
T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. Science (1995) 3.87
The promise of comparative genomics in mammals. Science (1999) 3.67
Esophageal motility in reflux disease before and after fundoplication: a prospective, randomized, clinical, and manometric study. Gastroenterology (2001) 3.38
A clinician's guide for conducting randomized trials in individual patients. CMAJ (1988) 3.35
Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma. Nat Med (1999) 3.18
Cytolytic activity of purified cytoplasmic granules from cytotoxic rat large granular lymphocyte tumors. J Exp Med (1984) 3.06
Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing. Molecular basis for the synergy between interferon-gamma and lipopolysaccharide. J Biol Chem (1993) 2.96
Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J Biol Chem (1996) 2.78
Characterization of the activation of latent TGF-beta by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system. J Cell Biol (1990) 2.65
Morphological and immunocytochemical characteristics of human tumor cell lines for use in a disease-oriented anticancer drug screen. Anticancer Res (1992) 2.62
Chemokines and T lymphocyte activation: I. Beta chemokines costimulate human T lymphocyte activation in vitro. J Immunol (1996) 2.62
Identification of polyphosphate-accumulating organisms and design of 16S rRNA-directed probes for their detection and quantitation. Appl Environ Microbiol (2000) 2.57
An index of scientific quality for health reports in the lay press. J Clin Epidemiol (1993) 2.47
Bladder calculi in dogs and cats. Vet Rec (1997) 2.41
Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nat Med (1997) 2.39
Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha. Am J Pathol (1999) 2.38
N of 1 randomized trials for investigating new drugs. Control Clin Trials (1990) 2.37
Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry. J Clin Oncol (1989) 2.33
Preventive eye care in people with diabetes is cost-saving to the federal government. Implications for health-care reform. Diabetes Care (1994) 2.30
Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. J Clin Invest (1995) 2.29
Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J Exp Med (1994) 2.18
An interferon-gamma-activated site (GAS) is necessary for full expression of the mouse iNOS gene in response to interferon-gamma and lipopolysaccharide. J Biol Chem (1997) 2.17
Purification and properties of cytoplasmic granules from cytotoxic rat LGL tumors. J Immunol (1984) 2.16
Molecular dating and biogeography of the early placental mammal radiation. J Hered (2001) 2.13
Natural killer (NK) cell activity in the rat. I. Isolation and characterization of the effector cells. J Immunol (1981) 2.12
Effects of prehospital care on outcome in patients with cardiac illness. Ann Emerg Med (1995) 2.09
Canine and feline parvoviruses can use human or feline transferrin receptors to bind, enter, and infect cells. J Virol (2001) 2.08
Catalysis research of relevance to carbon management: progress, challenges, and opportunities. Chem Rev (2001) 1.99
Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCID). Evidence that natural killer cells can mediate the specificity of marrow graft rejection. J Exp Med (1987) 1.95
Are complicated forms of celiac disease cryptic T-cell lymphomas? Blood (1998) 1.87
Extraskeletal osteosarcomas: a clinicopathologic study of 25 cases. Am J Surg Pathol (1998) 1.86
Outbreak of Infectious Hepatitis, Apparently Milk-borne. Am J Public Health Nations Health (1946) 1.72
Mechanism of cytotoxicity by natural killer (NK) cells. Annu Rev Immunol (1986) 1.72
Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft. Blood (2001) 1.71
Beta chemokines costimulate lymphocyte cytolysis, proliferation, and lymphokine production. J Leukoc Biol (1996) 1.70
Women living with HIV: disclosure, violence, and social support. J Urban Health (2000) 1.69
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Phenotypic characteristics of cell lines requiring interleukin 3 for growth. J Immunol (1982) 1.67
Microbiology of a nitrite-oxidizing bioreactor. Appl Environ Microbiol (1998) 1.67
The structure of the glycopeptide of human gamma G myeloma proteins. J Biol Chem (1971) 1.63
Identification of some of the major groups of bacteria in efficient and nonefficient biological phosphorus removal activated sludge systems. Appl Environ Microbiol (1999) 1.62
Induction of CD4+ T cell alloantigen-specific hyporesponsiveness by IL-10 and TGF-beta. J Immunol (1999) 1.61
Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation. J Clin Invest (1998) 1.61
Identification of human neutrophil-derived cathepsin G and azurocidin/CAP37 as chemoattractants for mononuclear cells and neutrophils. J Exp Med (1997) 1.60
Plasma renin and the antihypertensive effect of the orally active renin inhibitor aliskiren in clinical hypertension. Int J Clin Pract (2007) 1.60
Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR3+ endothelial cells. J Immunol (2001) 1.59
Mothers' mental illness and child behavior problems: cause-effect association or observation bias? J Am Acad Child Adolesc Psychiatry (2000) 1.56
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Direct evidence for the role of LGL in the inhibition of experimental tumor metastases. J Immunol (1985) 1.55
Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients. Clin Cancer Res (1999) 1.54
Second-generation integrated genetic linkage/radiation hybrid maps of the domestic cat (Felis catus). J Hered (2003) 1.53
T lymphocyte recruitment by interleukin-8 (IL-8). IL-8-induced degranulation of neutrophils releases potent chemoattractants for human T lymphocytes both in vitro and in vivo. J Clin Invest (1996) 1.53
Natural killer activity in the rat. II. Analysis of surface antigens on LGL by flow cytometry. J Immunol (1981) 1.51
Liposomes as targets for granule cytolysin from cytotoxic large granular lymphocyte tumors. Proc Natl Acad Sci U S A (1984) 1.49
[Irritable bowel syndrome: German consensus guidelines on definition, pathophysiology and management]. Z Gastroenterol (2011) 1.46
The Scandinavian Sarcoma Group Skeletal Metastasis Register. Survival after surgery for bone metastases in the pelvis and extremities. Acta Orthop Scand Suppl (2004) 1.45
The IWA Anaerobic Digestion Model No 1 (ADM1). Water Sci Technol (2002) 1.44
Inhibition of human B-cell lymphoma growth by CD40 stimulation. Blood (1994) 1.43
Hypoxia in human soft tissue sarcomas: adverse impact on survival and no association with p53 mutations. Br J Cancer (2001) 1.42
Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver. J Exp Med (1984) 1.41
Intradermal and subcutaneous leiomyosarcoma: a clinicopathological and immunohistochemical study of 41 cases. J Cutan Pathol (1996) 1.40
McDonald cerclage under pudendal nerve block. Am J Obstet Gynecol (1993) 1.40
Isolation of human and rat natural killer cells. J Immunol Methods (1982) 1.39
Use of the Index Case in the Study of Tuberculosis in Williamson County. Am J Public Health Nations Health (1942) 1.38
Bias influencing maternal reports of child behaviour and emotional state. Soc Psychiatry Psychiatr Epidemiol (2001) 1.38
Fronto-limbic brain structures in suicidal and non-suicidal female patients with major depressive disorder. Mol Psychiatry (2006) 1.37
Natural killer activity in the rat. III. Characterization of transplantable large granular lymphocyte (LGL) leukemias in the F344 rat. J Immunol (1984) 1.35
Measuring functional status in chronic lung disease: conclusions from a randomized control trial. Respir Med (1989) 1.35
The importance of comorbidity in HIV-infected patients over 55: a retrospective case-control study. Am J Med (1996) 1.34
Isolation and characterization of cloned DNA: the delta and beta globin genes in homozygous beta + thalassemia. Blood (1981) 1.33
Interleukin 3: possible roles in the regulation of lymphocyte differentiation and growth. Immunol Rev (1982) 1.33
Phenotypes of murine leukemia virus-induced tumors: influence of 3' viral coding sequences. J Virol (1992) 1.33
Oltipraz upregulates the nuclear factor (erythroid-derived 2)-like 2 [corrected](NRF2) antioxidant system and prevents insulin resistance and obesity induced by a high-fat diet in C57BL/6J mice. Diabetologia (2010) 1.33
Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo. Blood (2001) 1.33
Enhanced expression of annexin II in human pancreatic carcinoma cells and primary pancreatic cancers. Carcinogenesis (1993) 1.30
Studies of blood pressure in Tecumseh, Michigan. I. Blood pressure in young people and its relationship to personal and familial characteristics and complications of pregnancy in mothers. Am J Epidemiol (1980) 1.28
Familial occurrence of chronic respiratory disease and familial resemblance in ventilatory capacity. J Chronic Dis (1975) 1.27
Clinical usefulness of amitriptyline in fibromyalgia: the results of 23 N-of-1 randomized controlled trials. J Rheumatol (1991) 1.26
In vivo role of natural killer cells: involvement of large granular lymphocytes in the clearance of tumor cells in anti-asialo GM1-treated rats. J Immunol (1983) 1.26
Modifications to Rives technique for midline incisional hernia repair. Hernia (2001) 1.25
Accuracy of sphygmomanometers in hospital practice. Arch Intern Med (1970) 1.23
T gamma-lymphoproliferative disease and related disorders in humans and experimental animals: a review of the clinical, cellular, and functional characteristics. Blood (1984) 1.23
Measurement of the electron charge asymmetry in inclusive W production in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2012) 1.23
The Caenorhabditis elegans SH2 domain-containing protein tyrosine phosphatase PTP-2 participates in signal transduction during oogenesis and vulval development. Genes Dev (1998) 1.21
Gamma-band electroencephalographic oscillations in a patient with somatic hallucinations. Lancet (1998) 1.20
Infection of immune mast cells by Harvey sarcoma virus: immortalization without loss of requirement for interleukin-3. Mol Cell Biol (1985) 1.20